Basic Information
TRUSOPT OPHTHALMIC SOLUTION 2%
SOLUTION
Regulatory Information
SIN08880P
August 28, 1996
Prescription Only
Therapeutic
OPHTHALMIC
August 10, 2023
May 30, 2025
XS01EC03
Company Information
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Active Ingredients
DORZOLAMIDE HCl EQV DORZOLAMIDE
Strength: 2%
Detailed Information
Contraindications
**CONTRAINDICATIONS** TRUSOPT is contraindicated in patients who are hypersensitive to any component of this product.
Indication Information
**INDICATIONS** TRUSOPT Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with: - ocular hypertension - open-angle glaucoma - pseudoexfoliative glaucoma and other secondary open-angle glaucomas